0001127602-24-014445.txt : 20240507
0001127602-24-014445.hdr.sgml : 20240507
20240507163754
ACCESSION NUMBER: 0001127602-24-014445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240507
FILED AS OF DATE: 20240507
DATE AS OF CHANGE: 20240507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malik Fady Ibraham
CENTRAL INDEX KEY: 0001551778
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50633
FILM NUMBER: 24922653
MAIL ADDRESS:
STREET 1: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTOKINETICS INC
CENTRAL INDEX KEY: 0001061983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943291317
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
STREET 2: .
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 624-3000
MAIL ADDRESS:
STREET 1: 350 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-07
0001061983
CYTOKINETICS INC
CYTK
0001551778
Malik Fady Ibraham
350 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
1
EVP Research & Development
1
Common Stock
2024-05-07
4
M
0
14186
6.67
A
152603
D
Common Stock
2024-05-07
4
S
0
14186
65.11
D
138417
D
Common Stock
2024-05-07
4
S
0
1361
65.11
D
137056
D
Incentive Stock Option (Right to Buy)
6.67
2024-05-07
4
M
0
14186
0
D
2016-03-23
2026-02-23
Common Stock
14186
0
D
Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
2024-05-07